High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: A long-term followup study in a Danish cohort

Arthritis and Rheumatism

Volumn 63, Issue 10, 2011, Pages 3032-3037

  Dreyer, Lene ^a   Faurschou, Mikkel ^a   Mogensen, Mette ^b   Jacobsen, Søren ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CHILD; COLON CANCER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; INCIDENCE; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; MELANOMA; METASTASIS; MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; NOSE CAVITY CANCER; OVARY CANCER; PANCREAS CANCER; PARANASAL SINUS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SCHOOL CHILD; SKIN CANCER; SMALL INTESTINE CANCER; STOMACH CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CANCER; VAGINA CANCER; VERRUCA VULGARIS; VIRUS CARCINOGENESIS; VULVA CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; RISK;

EID: 80053544173     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30483     Document Type: Article

References (39)

1. Petterson T, Pukkala E, Teppo L, Friman C,. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 437-9.
2. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH,. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 761-8. (Pubitemid 27157584)
3. Cibere J, Sibley J, Haga M,. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001; 10: 394-400. (Pubitemid 32578613)
4. Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A,. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 66-71. (Pubitemid 34518083)
5. Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1481-90. (Pubitemid 40663940)
6. Parikh-Patel A, White RH, Allen M, Cress R,. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 2008; 19: 887-94.
7. Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke A, Gordon C,. Lupus and cancer. Lupus 2009; 18: 479-85.
8. Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P, et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 2007; 57: 619-25. (Pubitemid 46764052)
9. Klumb EM, Pinto A, Jesus G, Araujo M Jr, Jascone L, Gayer C, et al. Are women with lupus at higher risk of HPV infection? Lupus 2010; 19: 1485-91.
10. Tam LS, Chan PK, Ho SC, Yu MM, Yim SF, Cheung TH, et al. Natural history of cervical papilloma virus infection in systemic lupus erythematosus-a prospective cohort study. J Rheumatol 2010; 37: 330-40.
11. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 90: human papilloma viruses. Lyon (France): International Agency for Research on Cancer; 2007.
12. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633-8.
13. Blumenfeld Z, Lorber M, Yoffe N, Scharf Y,. Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus 1994; 3: 59-61. (Pubitemid 24105472)
14. Ognenovski VM, Marder W, Somers EC, Johnston CM, Farrehi JG, Selvaggi SM, et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 2004; 31: 1763-7. (Pubitemid 39202518)
15. Nyberg G, Eriksson O, Westberg NG,. Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum 1981; 24: 648-50. (Pubitemid 11099278)
16. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I: disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17: 468-77. (Pubitemid 28566323)
17. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II: disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998; 17: 478-84. (Pubitemid 28566324)
18. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM,. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999; 28: 75-80. (Pubitemid 29173250)
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. (Pubitemid 13221242)
20. Storm HH, Michelsen EV, Clemmensen IH, Pihl J,. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-9.
21. Danish National Board of Health. Cancer incidence in Denmark 2008. Copenhagen: Danish National Board of Health 2009. p. 5.
22. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 59: hepatitis viruses. Lyon (France): International Agency for Research on Cancer; 1994.
23. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 67: human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon (France): International Agency for Research on Cancer; 1996.
24. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 70: Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon (France): International Agency for Research on Cancer; 1997.
25. Fioriti D, Pietropaolo V, Dal Forno S, Laurenti C, Chiarini F, Degener AM,. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003; 16: 283-8. (Pubitemid 39011236)
26. Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH Jr, Johnson EM,. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34: 201-3.
27. Nindl I, Gottschling M, Stockfleth E,. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2007; 23: 247-59. (Pubitemid 47015794)
28. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949-57. (Pubitemid 38903528)
29. International Agency of Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 26: some antineoplastic and immunosuppressive agents. Lyon (France): International Agency for Research on Cancer; 1981.
30. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Cancer and AIDS Registries Linkage (CARL) study: pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009; 100: 840-7.
31. Wisgerhof HC, van der Geest LG, de Fijter JW, Haasnoot GW, Claas FH, le Cessie S, et al. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol 2011; 35: 105-11.
32. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91. (Pubitemid 36459475)
33. Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N,. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 2008; 35: 100-5.
34. Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, et al, and the Viraskin Study Group. Cutaneous human papillomaviruses found in sun-exposed skin: β-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 876-83. (Pubitemid 47378937)
35. Frisch M, Mellbye M, Moller M,. Trends in incidence of anal cancer in Denmark. BMJ 1993; 306: 419-22. (Pubitemid 23045549)
36. Reekie J, Kosa C, Engsig F, d'Arminio Monforte A, Wiercinska-Drapalo, Domingo P, et al, for the EuroSIDA Study Group. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer 2010; 116: 5306-15.
37. Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. Rheumatol 2004; 31: 2151-5.
38. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, et al, for the HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women [published erratum appears in Lancet 2010;376:1054]. Lancet 2009; 374: 301-14.
39. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011; 364: 401-11.